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Abstract
2019 Society for the Study of Addiction While imaging studies have demonstrated volumetric differences
in subcortical structures associated with dependence on various abused substances, findings to date
have not been wholly consistent. Moreover, most studies have not compared brain morphology across
those dependent on different substances of abuse to identify substance-specific and substance-general
dependence effects. By pooling large multinational datasets from 33 imaging sites, this study examined
subcortical surface morphology in 1628 nondependent controls and 2277 individuals with dependence on
alcohol, nicotine, cocaine, methamphetamine, and/or cannabis. Subcortical structures were defined by
FreeSurfer segmentation and converted to a mesh surface to extract two vertex-level metrics-the radial
distance (RD) of the structure surface from a medial curve and the log of the Jacobian determinant (JD)that, respectively, describe local thickness and surface area dilation/contraction. Mega-analyses were
performed on measures of RD and JD to test for the main effect of substance dependence, controlling for
age, sex, intracranial volume, and imaging site. Widespread differences between dependent users and
nondependent controls were found across subcortical structures, driven primarily by users dependent on
alcohol. Alcohol dependence was associated with localized lower RD and JD across most structures, with
the strongest effects in the hippocampus, thalamus, putamen, and amygdala. Meanwhile, nicotine use
was associated with greater RD and JD relative to nonsmokers in multiple regions, with the strongest
effects in the bilateral hippocampus and right nucleus accumbens. By demonstrating subcortical
morphological differences unique to alcohol and nicotine use, rather than dependence across all
substances, results suggest substance-specific relationships with subcortical brain structures.
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ABSTRACT
While imaging studies have demonstrated volumetric differences in subcortical structures
associated with dependence on various abused substances, findings to date have not been
wholly consistent. Moreover, most studies have not compared brain morphology across those
dependent on different substances of abuse to identify substance-specific and substancegeneral dependence effects. By pooling large multi-national datasets from 33 imaging sites,
this study examined subcortical surface morphology in 1,628 non-dependent controls and
2,277 individuals with dependence on alcohol, nicotine, cocaine, methamphetamine, and/or
cannabis. Subcortical structures were defined by FreeSurfer segmentation and converted to a
mesh surface to extract two vertex-level metrics – the radial distance (RD) of the structure
surface from a medial curve and the log of the Jacobian determinant (JD) – that respectively
describe local thickness and surface area dilation/contraction. Mega-analyses were performed
on measures of RD and JD to test for the main effect of substance dependence, controlling for
age, sex, intracranial volume, and imaging site. Widespread differences between dependent
users and non-dependent controls were found across subcortical structures, driven primarily
by users dependent on alcohol. Alcohol dependence was associated with localized lower RD
and JD across most structures, with strongest effects in the hippocampus, thalamus, putamen,
and amygdala. Meanwhile, nicotine use was associated with greater RD and JD relative to
non-smokers in multiple regions, with strongest effects in the bilateral hippocampus and right
nucleus accumbens. By demonstrating subcortical morphological differences unique to
alcohol and nicotine use, rather than dependence across all substances, results suggest
substance-specific relationships with subcortical brain structures.

Keywords: addiction; structural MRI; substance dependence

Abbreviations: AlcD = alcohol dependence; NicD = nicotine dependence; CocD = cocaine
dependence; MetD = methamphetamine dependence; CbD = cannabis dependence; RD =
radial distance; JD = log of the Jacobian determinant; ICV = intracranial volume
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INTRODUCTION
Substance dependence is characterized by compulsive substance-seeking, and a loss of
control over intake, despite negative social, interpersonal, and occupational consequences 1.
Substance use disorder can be related to any of a number of licit and illicit substances,
including alcohol, cannabis, opioids, stimulants, and tobacco 1. While not all substance users
will experience problems related to use, a significant number will become dependent,
although the proportion differs between substances. Within the US alone, over 1.5 million
substance users are admitted to treatment facilities every year for problems related to
substance use 2, reflecting a huge personal cost, and a severe toll on social and economic
development. Substance dependence accounts for over 37.6 million disability-adjusted life
years (DALYs; i.e., number of years lost due to disability and premature mortality) globally
3

. Disability (mental health, social and emotional functioning) also increases with dependence

severity among users 4. Identifying biomarkers associated with dependence across different
substances (i.e. alcohol, tobacco, cannabis, opioids, stimulants) may greatly help our
understanding of dependence and its consequences, and improve the identification of
individuals most vulnerable to dependence-related harm.

Neuroimaging research over the years has attempted to elucidate brain-based biomarkers (i.e.
structure, function, and neurochemistry) that may indicate aberrant processes in dependence
on various substances 5. Separately, these studies have demonstrated volumetric differences
in common subcortical structures, including the hippocampus, amygdala, striatum, and
thalamus, in opioid, stimulant, alcohol, tobacco, and cannabis use disorders

6–10

. Such

findings are consistent with the proposed role of these striatal and limbic structures in
supporting processes (e.g., planning and decision making, reward, and memory) crucially
involved in the etiology of substance use and dependence

11,12

. However, studies have yet to

compare subcortical structure across multiple substances using the same methods, making it
difficult to infer substance-specific versus substance-general neural alterations characterizing
dependence. Furthermore, gross volumetric measures commonly employed by structural
imaging studies may be unable to capture more localized subcortical differences (i.e. focal
differences on the vertices or triangular mesh that make up the subcortical surface, as
opposed to a single volumetric value across the entire structure) that can either be
generalizable across substances of abuse or specific to particular substances. This is relevant
as structures such as the hippocampus, amygdala, and striatum may be functionally
segregated across their subregions and/or topology, given differences in gene expression,
5

receptor distributions (e.g. GABAA, dopamine, and cannabinoid receptors, and innervation
along the structure

13–19

. Different regions of these subcortical structures may therefore be

differentially associated with substance use and dependence. For example, the basolateral and
central amygdala are differentially recruited over the course of cocaine-seeking in rats 20. The
former is suggested to be relevant for the development of substance-seeking ‘habit’, while the
latter is thought to be responsible for its long-term maintenance, reflecting unique but
complementary roles in the etiology of substance use 20. The dorsal and ventral regions of the
hippocampus are also differentially implicated in context-induced and cue-induced
reinstatement of substance use, due to their greater involvement in cognitive and affective
functions respectively

16,21,22

. Different substances of abuse are further thought to have

differing cellular and molecular pathways to dependence, raising the potential of substancespecific dependence effect 23. These observations motivated us to consider more fine-grained
shape differences in subcortical morphology when delineating individual substance
dependence-related effects on the brain.

This study was conducted by the Addiction working group of the Enhancing NeuroImaging
Genetics through Meta-Analysis (ENIGMA) Consortium, which leverages already collected
neuroimaging datasets to overcome limitations of sample size and statistical power in
identifying biomarkers of substance dependence

24,25

. Our previous study examining

FreeSurfer-segmented subcortical volumes across a combined sample of 23 research sites
identified substance-specific effects of alcohol dependence in the amygdala, hippocampus,
nucleus accumbens, and putamen 26. A nonlinear support vector machine was further able to
classify alcohol dependence and nicotine dependence above chance levels (despite there
being no significant nicotine dependence effects on individual subcortical volumes),
suggesting that there may be nonlinear or multivariate patterns of effects across multiple
brain areas not captured by standard univariate analysis of regional volumes. Building on this
result, this study sought to characterize substance-general and substance-specific shape
variation across the subcortical surfaces, which might better identify fine-grained regional
effects not captured by a single volumetric measure (i.e. as was the limitation of our previous
paper, Mackey et al., 2018). This study contained pooled neuroimaging data from 33 research
sites, adopting a surface-based approach used to quantify subcortical shape variability (i)
between all dependent users and non-dependent controls, (ii) across dependence groups
(alcohol, nicotine, cocaine, methamphetamine, or cannabis) and non-dependent controls, and
(iii) across nicotine use status. This will provide insight into whether dependence on different
6

substances of abuse may be associated with unique and localised effects on the brain,
specifically on subcortical structures. In turn, such brain effects may have the potential to
serve as useful biomarkers for risk factors or evidence of recovery from substance
dependence.

MATERIALS AND METHODS
Case and control data were contributed from 33 scanning sites from the ENIGMA addiction
working group 25; http://enigmaaddiction.com). This included a total of 1,535 non-dependent
controls, and 2,270 individuals with a primary substance dependence diagnosis (according to
DSM-IV criteria) on one of five substances: alcohol (AlcD), nicotine (NicD), cocaine
(CocD), methamphetamine (MetD), and cannabis (CbD), although ~8% of dependent users
met criteria for dependence on more than one substance. Cases were excluded if criteria were
met for any lifetime history of central nervous system disease, or a current axis I diagnosis
apart from substance dependence, apart from mood and anxiety disorders. Non-dependent
controls may have used these substances (i.e. mainly alcohol and nicotine), but did not meet
diagnostic criteria or were not assessed for substance dependence. Individual site information
and diagnostic instrument is provided in Supplementary Table 1. All subjects provided
written informed consent, and all procedures were in accordance with the Declaration of
Helsinki.

MRI Data Processing
Site-specific scanner and acquisition details for T1-weighted MR images are available in
Supplementary Table 1. All scans were prepared (either centrally at the University of
Vermont or at the respective individual sites) using the FreeSurfer image analysis
environment (http://surfer.nmr.mgh.harvard.edu/) version 5.3.0, to segment 14 subcortical
regions (i.e., bilateral accumbens, amygdala, caudate, hippocampus, pallidum, putamen, and
thalamus) from surrounding brain tissue. All FreeSurfer output underwent quality control at
each site, according to an established protocol (http://enigma.ini.usc.edu/protocols/imagingprotocols/), which included outlier detection and visual inspection of all data. A second level
of quality control was also performed on a random selection of participants from each site,
centrally at the University of Vermont.

Morphometric analysis on the FreeSurfer-segmented subcortical regions was performed at
the University of Vermont. This entailed converting subcortical boundaries to a mesh surface
7

using the Medial Daemons method

27,28

; http://enigma.ini.usc.edu/ ongoing/enigma-shape-

analysis/). This step includes registration of the FreeSurfer-segmented subcortical structures
to a master template based on brain images from 200 young adults created by the University
of Southern California’s Imaging Genetics Center team. By matching their shape curvatures
and medial features to a master template, mesh representations of the subcortical boundaries
were generated. All resulting mesh reconstructions were visually inspected by Y.C. for
quality control. Reconstructions that had significant artifacts (e.g. spikes, holes) or were
grossly inaccurate upon visual inspection (2.19% of generated structures) were excluded.
Finally, two vertex-level metrics were derived from the mesh surface, to quantify subcortical
shape. This included (i) the radial distance (RD), which is the distance between each surface
vertex and a skeleton core created along the long axis of the structure; and (ii) the natural
logarithm of the Jacobian determinant (JD), which represents the surface dilation ratio
necessary to map corresponding vertices on the subject-specific surface to the surface of the
master template. The logarithm is used to obtain a distribution that is closer to Gaussian. RD
and JD capture surface measures akin to ‘thickness (from a central skeleton)’ and ‘area’
respectively, 29, and are only weakly correlated (i.e., correlation coefficient from our sample,
r = .0228, CI = [.0226, .0230]). They thus complement each other in providing information
on localized grey matter changes across subcortical structures. The number of vertices per
structure was consistent across subjects, as defined by the master template (accumbens = 930;
amygdala = 1368; caudate = 2502; hippocampus = 2502; putamen = 2502; thalamus = 2502;
pallidum = 1254). See Fig. 1 for an overview of the vertex-wise shape metrics employed.

Statistical Analysis
Three sets of tests examined substance-general and substance-specific correlates of
dependence, using an optimized split-half strategy, described in the later paragraph. The first
set (model I: substance-general model) assessed the main effect of dependence on any
substance (i.e., dependent users vs. non-dependent control). In these analyses, individuals
reporting dependence on one or more substance were included.

The second set (model II: substance-specific model) assessed the main effect of individual
substances of dependence (i.e. AlcD, NicD, CocD, MetD, CbD, versus non-dependent
controls as a fixed factor with 6 levels). In the second set of analyses, individuals who were
dependent on more than one substance were excluded, to clarify the association between
dependence on individual substances and subcortical morphology. However, non-dependent
8

occasional substance use (e.g. recreational alcohol use in either group) was not excluded.
Effect of AlcD was further validated in a post-hoc analysis with a subsample of 171 AlcD
participants versus non-dependent controls, to ensure that any observed AlcD effects were
not due to their comparatively larger sample (n=830) relative to other substance-user groups
in this study (n=171-565). The subsample of 171 AlcD participants were created by
systematically selecting one in five AlcD participants, ordered by site, sex, and age, to ensure
that these covariates were matched across selected and non-selected samples.

The third set of analyses (model III: nicotine-disambiguation model) investigated nicotine use
effects. The large number of non-dependent controls and individuals diagnosed with
dependence who use nicotine may have affected the search for nicotine-related results in the
second model. This is particularly important as individual studies that recruited users on
AlcD, CocD, MetD, and CbD may not necessarily screen for nicotine use or dependence.
Consequently, the third set of analyses compared three groups: individuals with NicD, nondependent controls who use nicotine, and non-dependent controls who do not use nicotine.
Similar to the method in our previous paper 26, data for the three models were analysed using
an optimized split-half strategy whereby the data were first split into two halves matched for
site, age, sex, and intracranial volume. Subsequently, the series of linear models were tested
on each separate half, on the RD and JD measures of each subcortical structure, controlling
for participants’ age, sex, intracranial volume (ICV, to account for premorbid head size), and
imaging site. All outputs were corrected using a regional searchlight false discovery rate
(FDR) method 30 at q =.05, conservatively treating the 14 subcortical structures (i.e., bilateral
accumbens, amygdala, caudate, hippocampus, pallidum, putamen, and thalamus) and two
metrics (RD and JD) in each model as a single family of tests. Lastly, the corresponding
outputs across the split halves were overlaid to identify common regions of significance (i.e.,
vertices that were significant across both splits, henceforth referred to as ‘overlap’).

RESULTS
Demographic information for the full sample is presented in Table 1. In general, dependent
samples included more males, were older, and exhibited greater ICV than non-dependent
controls. Association between sex, age, and ICV are also presented graphically in
Supplementary Figures 1 and 2. To control for these factors, sex, age, and ICV were included

9

as covariates in the linear models. The effects of sex, age, and ICV on RD and JD are also
presented graphically in Supplementary Figure 3.

Model I: Substance-general Model
Dependent users were compared to non-dependent controls. On average, dependent users
exhibited lower RD and JD values relative to non-dependent controls in the hippocampus and
amygdala, diffuse areas of the thalamus, and the right nucleus accumbens (Fig. 2).

Model II: Substance-specific Model
For this model, individuals with dependence on multiple substances (~8%) were excluded,
resulting in a reduced sample size of 1,535 non-dependent controls and 2,085 dependent
users. No significant differences emerged from comparisons of NicD vs. non-dependent
controls, CocD vs. non-dependent controls, MetD vs. non-dependent controls, or CbD vs.
non-dependent controls. However, AlcD demonstrated significantly smaller RD and JD
values, particularly across bilateral hippocampus and putamen, and the right amygdala and
thalamus (Fig. 3). These regions of significance roughly correspond to regions identified in
Model I. Post-hoc analysis on a smaller subsample of 171 AlcD participants (i.e. the sample
size of the smallest substance dependence group in our study) similarly showed significantly
smaller RD and JD values relative to non-dependent controls, suggesting that the observed
alcohol-specific effect was not due to the comparatively larger AlcD sample relative to other
substance-user groups in our study (n=171-565).

Model III: Nicotine-disambiguation Model
Finally, model III was run to clarify the potential effect of NicD, by minimizing the potential
confounding influence of cigarette smoking in non-dependent controls. Control participants
recruited from all sites were separated into 918 non-smoking controls, 189 smoking controls,
after excluding participants without information on smoking status. These groups, and the
group of 565 NicD participants that were originally recruited by sites that tested for smoking
effects, were compared. NicD participants demonstrated significantly higher RD and JD
values relative to non-smoking controls, indicating greater volume and surface area across
bilateral regions of the hippocampus, thalamus, putamen, and the right nucleus accumbens
(Fig. 4).

10

Similarly smoking controls (who were not assessed for nicotine dependence by the recruiting
sites) demonstrated inflated structures relative to non-smoking controls, across the
hippocampus, thalamus, diffuse regions of the putamen, and the right nucleus accumbens
(Fig. 5). There was no significant difference between NicD and smoking controls.

Common regions of significance across both splits (i.e., overlap) are reported in Table 2 as
the percentage of significant vertices relative to the total number of vertices across each
structure.

DISCUSSION
Our previous volumetric mega-analysis of individuals dependent on one of five substances
(alcohol, nicotine, cocaine, methamphetamine, and cannabis) found lower amygdala,
hippocampus, nucleus accumbens, and putamen volume in alcohol dependent relative to nondependent controls, but no subcortical associations specific to dependence on any of the other
substances

26

. The current follow-up investigation adopts a more sensitive measure that

allows the quantification of localized differences at the vertex-level to closely examine
subcortical surface changes that may not have been detectable in our previous study. In a
larger combined sample of 3,805 individuals, we demonstrated lower RD and JD values
consistent with lower thickness and surface area in subcortical structures associated with
substance dependence, mainly along the hippocampus, amygdala, thalamus, and accumbens,
across substances of abuse. Such differences were driven by alcohol dependence and no
subcortical differences were observed for cocaine, methamphetamine, or cannabis users in
relation to non-dependent controls, in agreement with our previous paper

26

. Further

examination of nicotine dependence relative to non-smoking controls, and smoking controls
relative to non-smoking controls, surprisingly demonstrated an inverse association of higher
RD and JD values consistent with greater thickness and greater surface area across the
hippocampus, thalamus, and right accumbens in both nicotine dependence and smoking
controls relative to non-smoking controls.

The striking alcohol-specific effect on subcortical structures (in particular, the striatal and
limbic structures) is consistent with our previous ENIGMA study on gray matter volume in
substance dependence, which demonstrated lower volume in widespread cortical and
subcortical regions specific to alcohol dependence

26

. The absence of a subcortical

11

association with cocaine, methamphetamine, and cannabis is interesting given the literature
implicating striatal and limbic structures in the development of dependence towards these
substances

7,31

. To ensure that the observed alcohol-specific effect was not due to the

comparatively larger alcohol dependence sample (n=830) relative to other substances
(n=171-565) in our study, we re-ran the substance-specific model with a subsample of 171
alcohol dependence users. Results remained consistent and significant, suggesting that
alcohol dependence effect was robust, even across a much smaller sample. The individual
effects of other illicit substances on brain morphology may be subtler than previously
assumed 6,7,10. Alternatively, various moderating influences such as quantity of substance use
and timed developmental exposure may be relevant in considering brain morphology as
alcohol use typically starts earlier than the other illicit drugs (e.g. 50% of those who ever
used alcohol starts at age 14-21, compared to age 16-28 for cannabis and cocaine

32

).

Unfortunately, comparison of use level across different substances was not possible in the
present samples, as similar substance use histories were not obtained on all subjects at the
participating sites. An important goal for future studies will be to examine the impact of age
of onset and lifetime quantity of use on morphological measures in alcohol dependence.

While nicotine dependence effects were not observed in Model II when segregating users into
their substance of choice, differences were observed in Model III when comparing nicotinedependent users to non-smoking controls. The lack of effect of the former model may be due
to the confounding influence of smoking status within the non-dependent control sample.
Control samples collected by sites that seek to examine the effect of other illicit substances
(e.g. cannabis, cocaine, methamphetamine) often do not account for smoking status in their
samples or deliberately seek to match groups on cigarette use levels. By segregating nonsmoking and smoking controls, Model III sought to tease apart the influence of occasional
cigarette smoking relative to dependence. Finding greater RD and JD in nicotine-dependent
users relative to non-smoking controls in the hippocampus, putamen, and thalamus, was in
agreement with studies linking greater putamen volume with cigarette smoking

33,34

, but in

contrast to previous evidence of smaller thalamus and hippocampus in chronic cigarette
smokers relative to non-smokers

35–37

. Some studies have also reported no thalamic or

hippocampal volume difference in smokers relative to non-smokers

34,38

, reflecting the

inconsistency of current evidence on nicotine dependence. By pooling a combined sample of
1,672 subjects, adopting a more sensitive measure of vertex-level morphology, and requiring
split-half replication, this study provides evidence for a reinterpretation of cigarette smoking12

related effects on brain morphology. The smoking-related effect was not only observed
between nicotine dependence and non-smoking controls, but also between smoking controls
(who were not diagnosed with a nicotine dependence) and non-smoking controls, suggesting
structural differences associated with use rather than dependence. The proposed exposurerelated effect (as opposed to dependence-related effect) of cigarette smoking is supported by
a study demonstrating a dose-dependent relationship between nicotine use and enlarged
putamen volume

33

. Nicotinic receptors, that are particularly densely located along regions

where effects were observed (i.e. hippocampus, thalamus, basal ganglia)
paradoxically upregulated in response to chronic nicotine exposure

40,41

39

, and are

, may underlie the

observed morphological differences.

It is interesting to note that similar cigarette-smoking related effects (i.e. greater RD and JD
in the hippocampus, thalamus, and putamen) are not apparent in other substance-dependent
users in our sample, given the high comorbidity between cigarette smoking and other
substance use, particularly cannabis

42,43

. Subcortical morphometry may be subject to an

interactive effect between nicotine and other substance use. For example, the typically
observed subcortical differences in users dependent on methamphetamine, cocaine, or
cannabis

6,7,10

may have been counteracted by an opposing cigarette-smoking effect.

Unfortunately, the low number of methamphetamine-, cocaine-, or cannabis-dependent
subjects who are also non-smokers, and the lack of well-characterized smoking level
information within these substance-dependent users prevents an interrogation of the
interactive effect between cigarette smoking and other substance use/dependence in brain
structural effects.

A key structure emerging from this comprehensive examination of substance-related
subcortical morphology is the hippocampus, being notably implicated (up to >40% of the
structure’s surface) across the examined models. The hippocampus is a crucial structure for
learning and memory - its function is central to substance-related memory processes
including reinforcement learning and reinstatement of substance use

44

. The observed

hippocampal effect was mostly confined to the hippocampal head and inferior body of the
left hippocampus, roughly coinciding with the cornu ammonis (CA1) and subicular regions
45

. The CA1 is thought to be important for input integration, and contains a high density of N-

methyl-D-aspartate (NMDA) receptors that are modulated by substance use, in particular
alcohol

46,47

. Alcohol-associated NMDA effects are further thought to contribute to alcohol
13

tolerance and dependence 47. The subiculum receives input from the CA1, and along with the
CA1, provides the main hippocampal outflow to a range of cortical and subcortical sites

45

.

Both the CA1 and subiculum are particularly affected in neurodegenerative disorders such as
Alzheimer’s disease

48

, reflecting regional vulnerability to age-related atrophy, that may

further be amplified by chronic alcohol abuse

49

. Further, the anterior thalamic sub-region

was also found in this study to be preferentially affected relative to other sub-regions of the
thalamus. The anterior thalamus is primarily connected to the hippocampus and frontal
cortex, with reduced thalamo-frontal projections and anterior thalamic volume being
particularly associated with increased age and cognitive (attention and memory) decline 50,51.
The selective vulnerability of the anterior thalamus may further extend to alcohol
dependence, as demonstrated by this study.

While effects observed in the amygdala were relatively small and diffuse, across both the
lateral and basal regions 52, they were observed mostly in the right amygdala. This laterality
effect is in line with previous studies demonstrating a stronger association between the right
(vs. left) amygdala with substance dependence 53, and risk for developing alcohol dependence
54

. Findings from the latter study also suggest that an amygdala effect may precede

dependence. The basolateral amygdala, implicated in our study, is also argued to be
important for reward learning, motivation, and decision making, and therefore relevant in the
early stages and acquisition of substance dependence (whereas the central amygdala is
thought to be more involved in stress, negative reinforcement and maintenance of
dependence)

20,55,56

. However, it should be noted that the cross-sectional nature of this study

prevents us from confirming a causal role of subcortical differences across the trajectory of
substance dependence. Large scale, longitudinal studies that track the trajectory of brain
development and substance use, such as the ABCD study (https://abcdstudy.org/) will be
beneficial in clarifying the direction of association between substance use, dependence, and
brain morphology.

The current findings should be interpreted in the light of several limitations. First, the
datasets from multiple sites were collected under differing protocols and scanner sequences.
The diagnostic instruments adopted by the imaging sites for segregating dependence from
controls also differ. While these instruments are all validated and reliable, the inter-site
differences may limit the specificity of study findings. This study attempted to mitigate the
site issues in scanning and diagnosis by having a single rater visually inspect all subcortical
14

reconstructions and by incorporating site factors in all the statistical models. Conversely, a
benefit of making inference from multi-site data means that findings might have greater
generalizability to the wider population, due to the collation of larger samples

57

. A second

concern of adopting a multi-site approach is in the interpretability of findings, particularly in
relation to the spectrum of dependence severity, lifetime use quantity, or other clinical
variables of interest such as those that index quality of life and wellbeing. The latter is
particularly relevant for their potential confounding influence on observed brain differences.
For example depressive symptoms and mood disorders, which are highly comorbid in
substance dependence

58

, have also been associated with alterations of subcortical volumes

(e.g., reduction in hippocampal volumes)

59

. However, as not all sites in the current study

collected information on depressive symptoms, or adopted common instruments in measuring
them, their confounding influence on the current study findings cannot be ruled out. Moving
forward, a standardized approach to recruiting and testing future samples (i.e., wherein all
future substance dependence studies should collect information on duration, frequency, and
quantity of substance use, and mood and anxiety symptoms, at the minimum) will be
beneficial to allow for standardization and comparisons across datasets. This approach may in
turn facilitate collaboration and crosstalk across studies, in clarifying substance-general and
substance-specific brain correlates.

To conclude, our comprehensive examination of subcortical morphology in the largest
dependent user sample to date revealed significant alcohol and nicotine-specific effects on
subcortical structures, in particular the hippocampus, thalamus, and putamen. By contrast, the
effect of illicit substance dependence on brain volume was found to be minimal. Such
findings might warrant a revised understanding of the structural correlates of addiction. It is
possible that the brain-based effects of illicit substances may not be evident with
morphological measurements, but may instead be confined to functional or connectivityrelated differences.

15

16

Acknowledgements
We thank the ENIGMA Addiction Working Group for contributing the data necessary for
this work, and the ENIGMA Shape Analysis Team for developing the shape pipeline used in
this work. We also thank the Queensland Twin Imaging (QTIM) Study (Drs. Margie Wright,
Greig de Zubicaray, and Katie McMahon) for contributing the master template from which
the shape pipeline was developed.

Funding
This work was supported in part by National Institutes of Health (NIH) grant U54 EB020403
from the Big Data to Knowledge (BD2K) program. Dr. Y Chye was supported by the
Monash Bridging Postdoctoral Fellowship. Data collection: Dr. CRK Ching was supported
by grants NIA T32AG058507, NIH/NIMH 5T32MH073526, and NIH grant U54EB020403.
Dr. J Cousijn and Dr. AE Goudriaan received funding for the Cannabis Prospective Study
from Netherlands Organization for Health Research and Development (ZonMW) grant
31180002 from Netherlands Organization for Scientific Research (NWO). Dr. A Dagher
received support from the Canadian Institutes for Health Research. Dr. H Garavan and Dr. JJ
Foxe received funding from the National Institute on Drug Abuse (NIDA) grant R01DA014100. Dr. AE Goudriaan and Dr. RJ van Holst received funding from ZonMW grant
91676084 from NWO. Dr. O Korucuoglu received support for the neuro-ADAPT study from
the VICI grant 453.08.001 from the NWO, awarded to Dr RW Wiers. Dr CR Li received
funding from NIDA grants R01AA021449, R01DA023248, and K25DA040032. Dr. ED
London received support from NIH grants DA15179, DA022539, and DA024853, F30
DA021961 (KB), and MOI-RR-00865 (UCLA GCRC); endowments from the Katherine K.
and Thomas P. Pike Chair in Addiction Studies and Marjorie M. Greene Trust, Philip Morris
USA UCLA contract 20063287, and institutional training grants T32 DA 024635 (support of
Angelica Morales) and T32 MH17140 (support of Golnaz Tabibnia). Dr. M Luitjen and Dr.
DJ Veltman received support from the VIDI grant 016.08.322 from NWO, awarded to
Ingmar HA Franken. Dr. R. Momenan received support from the National Institutes of
Alcohol Abuse and Alcoholism (NIAAA)/NIH intramural research funding ZIA AA00012302 to the Clinical NeuroImaging Research Core. Dr. A Morales received support from NIDA
grant T32 DA024635. Dr MP Paulus received funding from National Institute of Mental
Health (NIMH) grant R01 DA018307. Dr. G. Pearlson received funding from the NIDA
grant R01 DA020709, and the NIAAA grants AA016599 and AA19036. Dr. R. MartinSantos received support from Plan Nacional sobre Drogas. Ministerio de Sanidad y Política
Social grant PNSD:2011/050 and SGR:2014/1114. Dr. L. Reneman received funding from
the Netherlands Organisation for health Research and development 40-00812-98-11002. Dr.
L Schmaal and Dr. DJ Veltman received funding from ZonMW grant 31160003 from NWO.
Dr. R Sinha received funding from NIDA (PL31-1DA024859-01), NIH National Center for
Research Resources (UL1-RR24925-01), and NIAAA grant (R01-AA013892). Dr. Z Sjoerds
and Dr. DJ Veltman received funding from ZonMW grant 31160004 from NWO. Dr. N
Solowij received support from the Clive and Vera Ramaciotti Foundation for Biomedical
Research, the National Health and Medical Research Council Project grant 459111 and
Australian Research Council Future Fellowship FT110100752. Dr. D Stein received support

17

from the South African Medical Research Council. Dr. EA Stein received support from the
Intramural Research Program of the National Institute on Drug Abuse (NIH). Dr. M Yücel
received support from the National Health and Medical Research Council Fellowship
1117188 and the David Winston Turner Endowment Fund.

Competing Interests
The authors report no competing interest. Dr. CRK Ching and Dr. PM Thompson receives
partial research support from Biogen, Inc. (Boston), for research unrelated to the topic of this
manuscript. Dr. M Yücel has received funding from Monash University, and Australian
Government funding bodies such as the National Health and Medical Research Council
(NHMRC), the Australian Research Council (ARC), and the Department of Industry,
Innovation and Science. He has also received philanthropic donations from the David
Winston Turner Endowment Fund, as well as payment from law firms in relation to court
and/or expert witness reports.
Data Accessibility
The summary data on which the analyses were performed are available from the
corresponding author upon reasonable request.

Authors contribution
PMT, PC, HG, and SM designed the study. BG and CRKC designed the study’s method. AB,
SB, SB, EC, JC, AD, JJF, AEG, RH, KH, NJ, AMK, OK, CSRL, EDL, VL, ML, RMS, SM,
RM, AM, CO, MPP, GP, LR, LS, RS, NS, DJS, EAS, DT, AU, RVH, DJV, AVG, RWW,
and MY collected the data. YC analysed the data with supervision from SM and HG. YC
wrote the first draft with close input from SM and HG. All other authors provided intellectual
feedback on the final draft.

18

REFERENCES
1.

American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders,
Fifth Edition (DSM-5). Arlington, VA: American Psychiatric Publishing; 2013.

2.

Substance Abuse and Mental Health Services Administration C for BHS and Q. Treatment
Episode Data Set (TEDS): 2005-2015. State Admissions to Substance Abuse Treatment
Services. BHSIS Seri. Rockville, MD: Substance Abuse and Mental Health Services
Administration; 2017.

3.

Whiteford HA, Degenhardt L, Rehm J, et al. Global burden of disease attributable to mental
and substance use disorders : findings from the Global Burden of Disease Study 2010. Lancet.
2013:1575-1586. doi:10.1016/S0140-6736(13)61611-6

4.

Grant BF, Saha TD, Ruan WJ, et al. Epidemiology of DSM-5 drug use disorder - Results from
the national epidemiologic survey on alcohol and related conditions-III. JAMA psychiatry.
2016;73(1):39-47. doi:10.1001/jamapsychiatry.2015.2132

5.

Garrison KA, Potenza MN. Neuroimaging and biomarkers in addiction treatment. Curr
Psychiatry Rep. 2014;16(12):513. doi:10.1007/s11920-014-0513-5

6.

Meyerhoff DJ. Structural neuroimaging in polysubstance users. Curr Opin Behav Sci.
2017;13:13-18. doi:10.1016/j.cobeha.2016.07.006

7.

Hall MG, Alhassoon OM, Stern MJ, et al. Gray matter abnormalities in cocaine versus
methamphetamine-dependent patients: a neuroimaging meta-analysis. Am J Drug Alcohol
Abuse. 2015;41(4):290-299. doi:10.3109/00952990.2015.1044607

8.

Durazzo TC, Meyerhoff DJ, Nixon SJ. Chronic Cigarette Smoking: Implications for
Neurocognition and Brain Neurobiology. Int J Environ Res Public Health. 2010;7:3760-3791.
doi:10.3390/ijerph7103760

9.

Yang X, Tian F, Zhang H, et al. Cortical and subcortical gray matter shrinkage in alcohol-use
disorders: a voxel-based meta-analysis. Neurosci Biobehav Rev. 2016;66(37):92-103.
doi:10.1016/j.neubiorev.2016.03.034

10.

Lorenzetti V, Chye Y, Silva P, Solowij N, Roberts CA. Does regular cannabis use affect
neuroanatomy? An updated systematic review and meta-analysis of structural neuroimaging
studies. Eur Arch Psychiatry Clin Neurosci. 2019. doi:10.1007/s00406-019-00979-1

11.

Redish AD, Jensen S, Johnson A. A unified framework for addiction: vulnerabilities in the
decision process. Behav Brain Sci. 2008;31(4):415-437; discussion 437-487.
doi:10.1017/S0140525X08004986

12.

Koob GF. Neurobiological substrates for the dark side of compulsivity in addiction.
Neuropharmacology. 2009;56:18-31. doi:10.1016/j.neuropharm.2008.07.043

13.

Small SA, Schobel SA, Buxton RB, Witter MP, Barnes CA. A pathophysiological framework
of hippocampal dysfunction in ageing and disease. Nat Rev Neurosci. 2011;12(10):585-601.
doi:10.1038/nrn3085
19

14.

Balderston NL, Schultz DH, Hopkins L, Helmstetter FJ. Functionally distinct amygdala
subregions identified using DTI and high-resolution fMRI. Soc Cogn Affect Neurosci.
2015;10(12):1615-1622. doi:10.1093/scan/nsv055

15.

Haber SN. Corticostriatal circuitry. Dialogues Clin Neurosci. 2016;18(1):7-21.
doi:10.1002/bit.260190307

16.

Fanselow MS, Dong HW. Are the Dorsal and Ventral Hippocampus Functionally Distinct
Structures? Neuron. 2010;65(1):7-19. doi:10.1016/j.neuron.2009.11.031

17.

Fritschy J-M, Mohler H. GABAA-receptor heterogeneity in the adult rat brain: Differential
regional and cellular distribution of seven major subunits. J Comp Neurol. 1995;359:154-194.

18.

Herkenham M, Lynn AB, Little MD, et al. Cannabinoid receptor localization in brain. Proc
Natl Acad Sci U S A. 1990;87(5):1932-1936. doi:10.1073/pnas.87.5.1932

19.

Camps M, Cortes R, Gueye B, Probst A, Palacios JM. Dopamine receptors in human brain:
Autoradiographic distribution of D2 sites. Neuroscience. 1989;28(2):275-290.

20.

Murray J, Belin-Rauscent A, Simon M, et al. Basolateral and central amygdala differentially
recruit and maintain dorsolateral striatum-dependent cocaine-seeking habits. Nat Commun.
2015;6:10088. doi:10.1038/ncomms10088

21.

Degoulet M, Rouillon C, Rostain JC, David HN, Abraini JH. Modulation by the dorsal, but not
the ventral, hippocampus of the expression of behavioural sensitization to amphetamine. Int J
Neuropsychopharmacol. 2008;11(4):497-508.

22.

Rogers JL, See RE. Selective inactivation of the ventral hippocampus attenuates cue-induced
and cocaine-primed reinstatement of drug-seeking in rats. Neurobiol Learn Mem.
2007;87(4):688-692.

23.

Gupta S, Kulhara P. Cellular and molecular mechanisms of drug dependence: An overview
and update. Indian J Psychiatry. 2007;49(2):85-90.

24.

Thompson PM, Stein JL, Medland SE, et al. The ENIGMA Consortium: large-scale
collaborative analyses of neuroimaging and genetic data. Brain Imaging Behav.
2014;8(2):153-182. doi:10.1007/s11682-013-9269-5

25.

Mackey S, Kan K, Chaarani B, et al. Genetic imaging consortium for addiction medicine:
From neuroimaging to genes. Prog Brain Res. 2016;224:203-223.
doi:10.1016/bs.pbr.2015.07.026

26.

Mackey S, Allgaier N, Chaarani B, et al. Mega-analysis of gray matter volume in substance
dependence: General and substance-specific regional effects. Am J Psychiatry. October 2018.
doi:10.1176/appi.ajp.2018.17040415

27.

Gutman BA, Wang Y, Rajagopalan P, Toga AW, Thompson PM. Shape matching with medial
curves and 1-D group-wise registration. In: 9th IEEE International Symposium on Biomedical
Imaging (ISBI). ; 2012:716-719.

28.

Gutman BA, Madsen SK, Toga AW, Thompson PM. A family of fast spherical registration
20

algorithms for cortical shapes. In: Shen L, Liu T, Yap P-T, Huang H, Shen D, Westin C-F, eds.
Multimodal Brain Imaging Analysis. Springer International Publishing; 2013:246-257.
doi:10.1007/978-3-319-02126-3_24
29.

Wang Y, Song Y, Rajagopalan P, et al. Surface-based TBM boosts power to detect disease
effects on the brain: An N=804 ADNI study. Neuroimage. 2011;56(4):1993-2010.
doi:10.1016/j.neuroimage.2011.03.040

30.

Langers DRM, Jansen JFA, Backes WH. Enhanced signal detection in neuroimaging by means
of regional control of the global false discovery rate. Neuroimage. 2007;38:43-56.
doi:10.1016/j.neuroimage.2007.07.031

31.

van de Giessen E, Weinstein JJ, Cassidy CM, et al. Deficits in striatal dopamine release in
cannabis dependence. Mol Psychiatry. 2017;22(1):68-75. doi:10.1038/mp.2016.21

32.

Degenhardt L, Chiu WT, Sampson N, et al. Toward a global view of alcohol, tobacco,
cannabis, and cocaine use: findings from the WHO World Mental Health Surveys. PLoS Med.
2008;5:e141. doi:07-PLME-RA-0801 [pii] 10.1371/journal.pmed.0050141

33.

Das D, Cherbuin N, Anstey KJ, Sachdev PS, Easteal S. Lifetime cigarette smoking is
associated with striatal volume measures. Addict Biol. 2012;17(4):817-825.
doi:10.1111/j.1369-1600.2010.00301.x

34.

Yu R, Zhao L, Lu L. Regional grey and white matter changes in heavy male smokers. PLoS
One. 2011;6(11). doi:10.1371/journal.pone.0027440

35.

Durazzo TC, Meyerhoff DJ, Nixon SJ. Interactive effects of chronic cigarette smoking and age
on hippocampal volumes. Drug Alcohol Depend. 2013;133(2):704-711.
doi:10.1016/j.drugalcdep.2013.08.020

36.

Gallinat J, Meisenzahl E, Jacobsen LK, et al. Smoking and structural brain deficits: a
volumetric MR investigation. Eur J Neurosci. 2006;24(6):1744-1750. doi:10.1111/j.14609568.2006.05050.x

37.

Sutherland MT, Riedel MC, Flannery JS, et al. Chronic cigarette smoking is linked with
structural alterations in brain regions showing acute nicotinic drug-induced functional
modulations. Behav Brain Funct. 2016;12(1):1-15. doi:10.1186/s12993-016-0100-5

38.

Brody AL, Mandelkern MA, Jarvik ME, et al. Differences between smokers and nonsmokers
in regional gray matter volumes and densities. Biol Psychiatry. 2004;55(1):77-84.
doi:10.1016/S0006-3223(03)00610-3

39.

Rubboli F, Court JA, Sala C, et al. Distribution of nicotinic receptors in the human
hippocampus and thalamus. Eur J Neurosci. 1994;6:1596-1604. doi:10.1111/j.14609568.1994.tb00550.x

40.

Nashmi R, Xiao C, Deshpande P, et al. Chronic nicotine cell specifically upregulates
functional α4* nicotinic receptors: Basis for both Ttolerance in midbrain and enhanced longterm potentiation in perforant path. J Neurosci. 2007;27(31):8202-8218.
21

doi:10.1523/jneurosci.2199-07.2007
41.

Govind AP, Vezina P, Green WN. Nicotine-induced upregulation of nicotinic receptors:
Underlying mechanisms and relevance to nicotine addiction. Biochem Pharmacol.
2009;78(7):756-765. doi:10.1124/dmd.107.016501.CYP3A4-Mediated

42.

Degenhardt L, Lynskey MT, Hall WD. Alcohol, cannabis and tobacco use and the mental
health of Australians: A comparative analysis of their associations with other drug use,
affective and axiety disorders, and psychosis. Addiction. 2001;96:1603-1614.
doi:10.1080/09652140120080732

43.

Subramaniam P, McGlade EC, Yurgelun-Todd DA. Comorbid cannabis and tobacco use in
adolescents and adults. Curr Addict Reports. 2016;3(2):182-188. doi:10.1007/s11065-0159294-9.Functional

44.

Robbins TW, Ersche KD, Everitt BJ. Drug addiction and the memory systems of the brain.
Ann N Y Acad Sci. 2008;1141:1-21. doi:10.1196/annals.1441.020

45.

Van Leemput K, Bakkour A, Benner T, et al. Automated segmentation of hippocampal
subfields from ultra-high resolution in vivo MRI. Hippocampus. 2009;19(6):549-557.
doi:10.1002/hipo.20615

46.

Coultrap SJ, Nixon KM, Alvestad RM, Fernando Valenzuela C, Browning MD. Differential
expression of NMDA receptor subunits and splice variants among the CA1, CA3 and dentate
gyrus of the adult rat. Mol Brain Res. 2005;135(1-2):104-111.
doi:10.1016/j.molbrainres.2004.12.005

47.

Nagy J. Alcohol related changes in regulation of NMDA receptor functions. Curr
Neuropharmacol. 2008;6(1):39-54. doi:10.2174/157015908783769662

48.

Mueller SG, Weiner MW. Selective effect of age, Apo e4, and Alzheimer’s disease on
hippocampal subfields. Hippocampus. 2009;19(6):558-564. doi:10.1002/hipo.20614

49.

Pfefferbaum A, Lim KO, Zipursky RB, et al. Brain gray and white matter volume loss
accelerates with aging in chronic alcoholics: A quantitative MRI study. Alcohol Clin Exp Res.
1992;16(6):1078-1089. doi:10.1111/j.1530-0277.1992.tb00702.x

50.

Fama R, Sullivan E V. Thalamic structures and associated cognitive functions: Relations with
age and aging. Neurosci Biobehav Rev. 2015;54(2):29-37.
doi:10.1016/j.neubiorev.2015.03.008

51.

Hughes EJ, Bond J, Svrckova P, et al. Regional changes in thalamic shape and volume with
increasing age. Neuroimage. 2012;63(3):1134-1142. doi:10.1016/j.neuroimage.2012.07.043

52.

Saygin ZM, Kliemann D, Iglesias JE, et al. High-resolution magnetic resonance imaging
reveals nuclei of the human amygdala: manual segmentation to automatic atlas. Neuroimage.
2017;155(May 2016):370-382. doi:10.1016/j.neuroimage.2017.04.046

53.

Makris N, Gasic GP, Seidman LJ, et al. Decreased absolute amygdala volume in cocaine
addicts. Neuron. 2004;44:729-740. https://ac.els-cdn.com/S0896627304006907/1-s2.022

S0896627304006907-main.pdf?_tid=b73fc80e-cf42-11e7-8cea00000aab0f01&acdnat=1511327290_ddb61ff9f404958a105c086caf342b95.
54.

Hill SY, De Bellis MD, Keshavan MS, et al. Right amygdala volume in adolescent and young
adult offspring from families at high risk for developing alcoholism. Biol Psychiatry.
2001;49(11):894-905. doi:10.1016/S0006-3223(01)01088-5

55.

Wassum KM, Izquierdo A. The basolateral amygdala in reward learning and addiction.
Neurosci Biobehav Rev. 2015;57:271-283. doi:10.1002/cncr.27633.Percutaneous

56.

Koob GF. Brain stress systems in the amygdala and addiction. Brain Res. 2009;1293:61-75.
doi:10.1016/j.brainres.2009.03.038

57.

Turner JA. The rise of large-scale imaging studies in psychiatry. Gigascience. 2014;3(29):1-8.
doi:10.1186/2047-217X-3-29

58.

Lai HMX, Cleary M, Sitharthan T, Hunt GE. Prevalence of comorbid substance use, anxiety
and mood disorders in epidemiological surveys, 1990-2014: A systematic review and metaanalysis. Drug Alcohol Depend. 2015;154:1-13. doi:10.1016/j.drugalcdep.2015.05.031

59.

Schmaal L, Veltman DJ, van Erp TGM, et al. Subcortical brain alterations in major depressive
disorder: findings from the ENIGMA Major Depressive Disorder working group. Mol
Psychiatry. 2016;21(6):806-812. doi:10.1038/mp.2015.69

23

Table 1. Demographics of non-dependent controls and individuals with a substance dependence, across Models I - III (Mean (SD))
I

Non-dependent

Dependent usersa

controls
N = 1535

N = 2270

Sex (M/F %)

58.5/41.5

66.4/33.6*

Age (Years)

27.5 (9.9)

32.7 (10.7)*

ICV (106)b

1.44 (0.23)

1.49 (0.22)*

II

Non-dependent

AlcD

NicD

CocD

MetD

CbD

N = 830

N = 565

N = 309

N = 171

N = 210

controls
N = 1535
Sex (M/F %)

58.5/41.5

65.4/34.6*

57.5/42.5

78.3/21.7*

66.7/32.6*

69.5/30.5*

Age (Years)

27.5 (9.9)

32.9 (11.3)*

31.1 (9.9)*

39.1 (8.1)*

31.1 (9.1)*

25.6 (9.3)*

ICV (106)

1.44 (0.23)

1.53 (0.22)*

1.48 (0.22)*

1.41 (0.20)

1.55 (0.16)*

1.51 (0.19)*

III

Non-smoking

Smoking

controls

controls

N = 918

N = 189

NicD

N = 565

Sex (M/F %)

61.1/38.9

64.0/36.0

57.5/42.5

Age (Years)

29.7 (9.6)

28.9 (9.4)

31.1 (9.9)*

ICV (106)

1.41 (0.24)

1.52 (0.20)*

1.48 (0.22)*

a

Substance dependence include AlcD = alcohol, NicD = nicotine, CocD = cocaine, MetD = meth, and CbD = cannabis dependence

b

ICV = intracranial volume, measured in mm3

*p<.05. Each dependent group was compared against non-dependent controls (or non-smoking controls in Model III) with t-tests for Age and ICV and χ2 tests for Sex.

24

Table 2. Significant regions (as percentage of vertices, %) and average effect size (d) of differences in radial distance (RD) and Jacobian
determinant (JD) common across splits 1 and 2, across Models I – III.
Model

Contrast

Region

Radial Distance (RD)
Percentage of

d*

draw*

Jacobian Determinant (JD)
p

total region (%)
I

Dependent

Left

draw*

p

total region (%)

0

-

-

-

0.66

-0.128

-0.141

0.009

Hippocampus

3.24

-0.146

-0.162

0.005

28.70

-0.155

-0.169

0.005

non-

Thalamus

0.04

-0.127

-0.167

0.008

0.36

-0.152

-0.177

0.003

Accumbens

10.65

-0.143

-0.174

0.005

0

-

-

-

Amygdala

3.51

-0.172

-0.178

0.002

7.02

-0.149

-0.148

0.004

Hippocampus

1.04

-0.146

-0.137

0.004

22.06

-0.164

-0.171

0.003

Putamen

0

-

-

-

0.76

-0.150

-0.181

0.004

Thalamus

1.76

-0.138

-0.154

0.005

2.32

-0.167

-0.163

0.002

Hippocampus

4.68

-0.168

-0.188

0.004

31.53

-0.170

-0.184

0.004

Putamen

6.59

-0.155

-0.153

0.005

3.68

-0.143

-0.173

0.006

Accumbens

0

-

-

-

1.94

-0.156

-0.188
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*Average effect size (d) computed over remaining significant regions after overlap of splits 1 and 2. Raw effect size (draw) represents effect size without correcting for
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Figure Legend
Fig. 1. Overview of the vertex-wise shape metrics employed. (A) 3D model of subcortical structures within the brain space. (B) The radial
distance (RD) of a structure corresponds to the distance between each surface vertex and the structure’s medial skeleton. (C) The Jacobian
determinant (JD) corresponds to the deformation necessary to match the subject-specific structure to a template. A higher JD reflects a larger
‘surface area’ relative to the template.

Fig. 2. Subcortical difference between individuals with substance dependence and non-dependent controls. Bottom and top view of (i)
local surface thickness (radial distance, RD) and (ii) local area (natural logarithm of the Jacobian determinant, JD) differences across subcortical
structures in the left (left) and right hemispheres (right), in individuals with substance dependence compared to non-dependent controls. All
effects controlled for imaging site, sex, and age. Heat maps represent beta-values of the significant regions in each split half (SPLIT 1 and SPLIT
2). Overlap in significance across both splits are colored in blue in the last column (OVERLAP).

Fig. 3. Subcortical difference between individuals with alcohol dependence and non-dependent controls. Bottom and top view of (i) local
surface thickness (radial distance, RD) and (ii) local area (natural logarithm of the Jacobian determinant, JD) differences across subcortical
structures in the left (left) and right hemispheres (right), in individuals with an alcohol dependence (AlcD) compared to non-dependent controls.
All effects controlled for imaging site, sex, and age. Heat maps represent beta-values of the significant regions in each split half (SPLIT 1 and
SPLIT 2). Overlap in significance across both splits are colored in blue in the last column (OVERLAP).

Fig. 4. Subcortical difference between individuals with nicotine dependence and non-smoking controls. Bottom and top view of (i) local
surface thickness (radial distance, RD) and (ii) local area (natural logarithm of the Jacobian determinant, JD) differences across subcortical
structures in the left (left) and right hemispheres (right), in individuals with a nicotine dependence (NicD) compared to non-smoking controls.
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All effects controlled for imaging site, sex, and age. Heat maps represent beta-values of the significant regions in each split half (SPLIT 1 and
SPLIT 2). Overlap in significance across both splits are colored in blue in the last column (OVERLAP).

Fig. 5. Subcortical difference between smoking controls and non-smoking controls. Bottom and top view of (i) local surface thickness
(radial distance, RD) and (ii) local area (natural logarithm of the Jacobian determinant, JD) differences across subcortical structures in the left
(left) and right hemispheres (right), in smoking controls compared to non-smoking controls. All effects controlled for imaging site, sex, and age.
Heat maps represent beta-values of the significant regions in each split half (SPLIT 1 and SPLIT 2). Overlap in significance across both splits
are colored in blue in the last column (OVERLAP).
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